Elsevier

Medical Hypotheses

Volume 58, Issue 6, June 2002, Pages 491-495
Medical Hypotheses

Regular Article
Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysis

https://doi.org/10.1054/mehy.2001.1459Get rights and content

Abstract

The natural alpha-2 antagonist yohimbine promotes sympathetic activity by central as well as peripheral mechanisms, and yet in moderate doses dose not usually raise heart rate, increase blood pressure, or induce anxiety (in contrast to sympathomimetic drugs such as ephedrine). Administered prior to exercise, it boosts lipolysis and serum FFA levels both during and following exercise; blockade of adipocyte alpha-2 adrenoreceptors makes at least a modest contribution to this pro-lipolytic activity. These considerations suggest that pre-exercise administration of yohimbine will lower the respiratory quotient during and following exercise, thus promoting fat loss. Since yohimbine can potentiate postprandial insulin secretion, its bariatric benefits should be greatest if administered on a schedule that minimizes postprandial yohimbine activity. A possible synergism of yohimbine and caffeine should be explored. Pre-exercise yohimbine administration has the potential to down-regulate the lipoprotein lipase activity of visceral adipocytes, increase lipolysis in refractory gynoid fat depots, and improve the impaired lipolytic response to exercise in the elderly.

References (37)

  • D.L. Costill et al.

    Effects of caffeine ingestion on metabolism and exercise performance

    Med Sci Sports

    (1978)
  • S.K. Powers et al.

    Caffeine and endurance performance

    Sports Med

    (1985)
  • S. Flinn et al.

    Caffeine ingestion prior to incremental cycling to exhaustion in recreational cyclists

    Int J Sports Med

    (1990)
  • K. Donelly et al.

    The effects of two levels of caffeine ingestion on excess postexercise oxygen consumption in untrained women

    Eur J Appl Physiol

    (1992)
  • S.C. Souza et al.

    BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones

    Diabetes

    (1998)
  • A. Morales

    Yohimbine in erectile dysfunction: the facts

    Int J Impot Res

    (2000)
  • B. Zahorska-Markiewicz et al.

    Adrenergic control of lipolysis and metabolic responses in obesity

    Horm Metab Res

    (1986)
  • J. Galitzky et al.

    Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers

    Eur J Clin Invest

    (1988)
  • Cited by (21)

    • Use of enzymes in sports and energy drinks

      2022, Value-Addition in Beverages through Enzyme Technology
    View all citing articles on Scopus
    f1

    Correspondence to: Mark F. McCarty, Pantox Laboratories, 4622 Santa Fe Street, San Diego, CA 92109, USA

    View full text